Monitoring anticoagulation during extracorporeal membrane oxygenation in patients with acute respiratory failure
Critical Care volume 17, Article number: P126 (2013)
aPTT is a common tool for anticoagulation monitor ing during extracorporeal membrane oxygenation (ECMO). Thromboelasto graphy (TEG) is another available option in this setting.
A prospective observational study on 12 consecutive patients during venovenous ECMO. Anticoagulation was provided with unfractioned heparin titrated to an aPTT ratio target of 1.5 to 2. Kaolin-activated TEG (K-TEG) was contemporarily measured but did not guide heparin infusion. Baseline K-TEG reaction time (R) >20 minutes is accepted for anticoagulation but when it exceeds 90 minutes anticoagulation may be too great .
Mean ECMO duration was 9 ± 4 days. A total of 152 K-TEGs were collected. Comparison between aPTT and K-TEG R is reported in Table 1. Four patients (33%) had hemorrhagic complications. Neither aPTT nor K-TEG R were significantly different in patients with hemorrhagic events compared with patients without hemorrhagic events but the latter received a significantly lower total heparin dose (P = 0.0097).
Anticoagulation was excessive in more than one-half of the samples according to TEG monitoring, while negligible based on aPTT.
Oliver WC: Semin Cardiothorac Vasc Anesth. 2009, 13: 154-175. 10.1177/1089253209347384
About this article
Cite this article
Panigada, M., Mietto, C., Pagan, F. et al. Monitoring anticoagulation during extracorporeal membrane oxygenation in patients with acute respiratory failure. Crit Care 17 (Suppl 2), P126 (2013). https://doi.org/10.1186/cc12064
- Respiratory Failure
- Acute Respiratory Failure
- Prospective Observational Study
- Unfractioned Heparin